Skip to main content
. 2020 Aug 12;21(16):5784. doi: 10.3390/ijms21165784
ADA Anti-drug antibodies
αGAL A Alpha-Galactosidase A (enzyme)
ERT Enzyme replacement therapy
FD Fabry disease
GB3 Globotriaosylceramide
GLA Alpha-Galactosidase A (gene)
iADA Inhibiting anti-drug antibodies
LR Logistic regression
LysoGb3 Globotriaosylsphingosine
r- αGAL A Recombinant alpha-galactosidase A (enzyme)
RF Random forest
ROC-AUC Area under the receiver operating characteristic curve